Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
An article in the Milwaukee Journal Sentinal Online featured findings published in a recent paper by Maureen Durkin, PhD, DrPH, titled “Socioeconomic Inequality in the Prevalence of Autism Spectrum Disorder: Evidence from a U.S. Cross-Sectional Study.“
Using novel screens to sort through libraries of drugs already approved for use in human patients, a team of Wisconsin researchers has identified several compounds that could be used to treat a rare and deadly neurological disorder.
by Terry Devitt University Communications With more than 100 billion neurons and billions of other specialized cells, the human brain is a marvel of nature. It is the organ that makes people unique. Now, writing in the journal Cell Stem Cell (July 1, 2010), a team of scientists from the UW-Madison has identified a single …
If there is evidence that each of us, in our mind’s eye, has a unique and valuable take on the world, it hangs on walls of UW–Madison’s Waisman Center.
The March 22, 2010 issue of USA Today features a story on the dilemma faced by aging parents of adults with Down syndrome.
The Center for Investigating Healthy Minds at the University of Wisconsin–Madison’s Waisman Center will welcome His Holiness the 14th Dalai Lama to its public grand-opening celebration Saturday-Sunday, May 15-16. UW-Madison neuroscientist Richard Davidson established the Center for Investigating Healthy Minds (CIHM) to scientifically determine how healthy qualities of mind develop and to investigate interventions to …
Intriguingly, the new study suggests the presence or absence of the genes used to reprogram skin cells to become the blank slate pluripotent cells makes no difference in terms of their capacity to differentiate.
The February 9, 2010 issue of The Capital Times features a story on the recent retraction of a 1998 journal article claiming a link between childhood vaccines and autism.
The long struggle to move the most versatile stem cells from the laboratory to the clinic got another boost with an $8.8 million contract award to the Waisman Clinical Biomanufacturing Facility at the University of Wisconsin-Madison.
The research of Marsha Mailick Seltzer, PhD, was recently cited by Autism Speaks Chief Science Officer Geri Dawson, Ph.D., as part of a review of major scientific advances in autism research in 2010.
